The safety of dirlotapide in dogs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue SUPPL. 1, 2007, Pages 43-54

  Wren, J A ^a   King, V L ^a   Krautmann, M J ^a   Gossellin, J ^b   Kerlin, R L ^c   Hickman, M A ^c   Schmahai, T J ^c  

^a PFIZER INC   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; DIRLOTAPIDE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR; PLACEBO; SLENTROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOG; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ENZYME ACTIVITY; FEMALE; FOOD INTAKE; HISTOPATHOLOGY; INCIDENCE; LIVER NECROSIS; LOOSE FECES; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; VOMITING; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-OBESITY AGENTS; CARBAMATES; DOG DISEASES; DOGS; FEMALE; INDOLES; MALE; OBESITY; SAFETY;

CANIS FAMILIARIS;

EID: 34249812349     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00854.x     Document Type: Article

References (25)

1. Arnaud, J., Fortis, I., Blacher, S., Kia, D. Favier, A. (1991) Simultaneous determination of retinal α-tocopherol and β-carotene in serum by isocratic high-performance liquid chromatography. Journal of Chromatography, 572, 103 116.
2. Cornelius, C.E. (1989) Liver function. In Clinical Biochemistry of Domestic Animals. 4th edn. Ed. Keneko, J.J., pp. 364 397. Academic Press Inc., San Diego, USA.
3. Davidson, M.G., Geoly, F.J., Gilger, B.C., McLellan, G. J. Whitley, W. (1998) Retinal degeneration associated with vitamin E deficiency in hunting dogs. Journal of the American Veterinary Medical Association, 213, 645 651.
4. Duncan, J.R., Prasse, K.W. Mahaffey, E.A. (1994) Veterinary Laboratory Medicine: Clinical Pathology, 3rd edn, pp. 34, 51 179, Iowa State University Press, Ames, IA, USA.
5. Dunnett, C.W. (1955) A multiple comparison procedure for comparing several treatments with a control. Journal of the American Statistical Association, 50, 1096 1121.
6. Dunnett, C.W. (1964) New tables for multiple comparisons with a control. Biometrics, 20, 402 492.
7. Finco, D.R. (1997 Clinical Biochemistry of Domestic Animals, 5th edn. Eds Kaneko, J.J., Harvey, J.W. Bruss, M.L., p. 469. Academic Press Inc., San Diego, USA.
8. Gossellin, J., McKelvie, J., Sherington, J., Wren, J.A., Eagleson, J.S., Rowan, T.G. Sunderland, S.J. (2007a) An evaluation of dirlotapide to reduce the body weight of client-owned dogs in two placebo-controlled clinical studies in Europe. Journal of Veterinary Pharmacology and Therapeutics, 30 (Suppl. 1), 73 80.
9. Gossellin, J., Peachey, S., Sherington, J., Rowan, T.G. Sunderland, S.J. (2007b) Evaluation of dirlotapide, a novel microsomal triglyceride transfer protein inhibitor, for sustained weight loss in overweight Labrador retrievers. Journal of Veterinary Pharmacology and Therapeutics, 30 (Suppl. 1), 55 65.
10. Kirk, C.A., Wren, J.A., Boucher, J.F. Sunderland, S.J. (2007) Influence of dirlotapide, a microsomal triglyceride transfer protein inhibitor, on the digestibility of a dry expanded diet in adult dogs. Journal of Veterinary Pharmacology and Therapeutics, 30 (Suppl. 1), 66 72.
11. Laflamme, D. (1997) Development and validation of a body condition score system for dogs. Canine Practice, 22, 10 15.
12. Levin, S., Semler, D. Rubin, Z. (1993) Effects of two weeks of feed restriction on some common toxicologic parameters in Sprague-Dawley rats. Toxicologic Pathology, 21, 1 14.
13. Meyer, D. J., Coles, E. H. Rich, L. J. (1992) Veterinary Laboratory Medicine: Interpretation and Diagnosis, pp. 103 105. W.B Saunders Company, Philadelphia, PA, USA.
14. Pillai, S.R., Traber, M.G., Steiss, J.E. Kayden, H.J. (1993a) Depletion of adipose tissue and peripheral nerve α-tocopherol in adult dogs. Lipids, 28, 1095 1099.
15. Pillai, S.R., Traber, M. G., Steiss, J. E., Kayden, H. J. Cox, N.R. (1993b) α-tocopherol concentrations of the nervous system and selected tissues of adult dogs fed three levels of vitamin E. Lipids, 28, 1101 1105.
16. Robertson, D.G., Breider, M.A. Milad, M. A. (2001) Preclinical safety evaluation of avasimibe in beagle dogs; an ACAT inhibitor with minimal adrenal effects. Toxicological Sciences, 59, 324 334.
17. Schweigert, F.J., Uehlein-Harrell, S. Zucker, H. (1990) Effect of feeding on vitamin A concentrations in blood plasma of dogs. Journal of the Veterinary Medical Association, 37, 605 609.
18. Smith, J.E. Lunn, P.G. (1984) Albumin-synthesizing capacity of hepatocytes isolated from rats fed diets differing in protein and energy content. Annals of Nutrition and Metabolism, 28, 281 287.
19. Sokal, R. Rohlf, F.J. (1969) Biometry. W.H. Freeman & Co., San Francisco, USA.
20. Sokol, R.J., Heubi, J.E., Iannaccone, S.T., Bove, K.E. Balsitreri, W.F. (1984) Vitamin E deficiency with normal serum vitamin E concentrations in children with chronic cholestasis. New England Journal of Medicine, 310, 1209 1212.
21. Stockham, S.L. Scott, M.A. (2002) Fundamentals of Veterinary Clinical Pathology, pp. 320 409. Iowa State Press, Ames, IA, USA.
22. Tvedten, H.W. Whitehair, C.K. (1977) Torulopsis glabrata and vitamin A deficiency in dogs. American Journal of Veterinary Research, 38, 1941 1948.
23. Wren, J.A., Gossellin, J. Sunderland, S.J. (2007a) Dirlotapide: a review of its properties and role in the management of obesity in dogs. Journal of Veterinary Pharmacology and Therapeutics, 30 11 16.
24. Wren, J.A., King, V.L., Campbell, S.L. Hickman, M.A. (2007b) Biologic activity of dirlotapide, a novel microsomal triglyceride transfer protein inhibitor, for weight loss in obese dogs. Journal of Veterinary Pharmacology and Therapeutics, 30 33 42.
25. Wren, J.A., Ramudo, A.A., Campbell, S.L., King, V.L., Eagleson, J.S., Gossellin, J. Sunderland, S.J. (2007c) Efficacy and safety of dirlotapide in the treatment of obese dogs evaluated in two placebo-controlled, masked clinical studies in North America. Journal of Veterinary Pharmacology and Therapeutics, 30 81 89.